Mark B Busch, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4005 167th St, Country Club Hills, IL 60478 Phone: 708-799-0920 Fax: 708-799-6310 |
News Archive
Industry-leading automation solution provider Omron Automation Americas recently announced the release of an advanced yet intuitive solution for automating repetitive tasks in manufacturing. With built-in vision and a user-friendly, plug-and-play programming interface, the new TM Series Collaborative Robot works seamlessly with humans to enhance productivity and ensure safety.
OptiNose, a leader in nasal drug delivery systems, is pleased to announce the publication in Cephalalgia of results from its Phase II clinical study investigating the efficacy and tolerability of its novel, intranasal drug/device product for the treatment of migraine.
Ignyta, Inc., an oncology precision medicine biotechnology company, announced today that Justin Gainor, M.D., of the Massachusetts General Hospital Cancer Center, presented preliminary results from the ongoing Phase 1 dose escalation portion of a Phase 1/2 clinical trial of RXDX-101, Ignyta's proprietary oral tyrosine kinase inhibitor targeting solid tumor indications, at the International Association for the Study of Lung Cancer 14th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
Solicitors at Goodmans Law believe that the frequency with which medical negligence claims occur and are reported in the media could make patients wary of being treated in hospital.
Dartmouth Medical School cardiology researchers have discovered a new mechanism for what drives the growth of muscle tissue in the lining of injured heart vessels that can eventually lead to blockage.
› Verified 5 days ago